$OKLO

Narayanadas Vivek sold $21K of OKLO

Narayanadas Vivek (General Counsel & Secretary) sold 538 shares of Oklo Inc. (OKLO) at $39.88 on 2026-09-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Narayanadas Vivek
Published Sep 8, 2026, 8:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 8:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OKLO
Neutral
high confidence
Mentioned
$OKLO
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosed sale is small and unlikely to affect OKLO's stock price.

02

Market read

Limited relevance; the transaction size is trivial relative to market cap.

03

What to watch

Potential tax planning or portfolio rebalancing may drive the sale.

Relevance 2/10Novelty 2/10Timing: filing date 2026-09-08

Background

Form 4 filing discloses insider transactions; such filings are primary sources.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

General Counsel Narayanadas Vivek sold 538 shares for $21,455 via a 10b5-1 plan.

Expected impact

No material price movement expected.

Evidence & confidence

The transaction is small relative to holdings and typical for 10b5-1 plans.

Market effects

No broader sector impact; insider sale is company‑specific.

None.

None.

Counterpoint

The sale could be routine; investors should not read it as a negative signal.

Key entities

  • Oklo Inc.

    US-listed nuclear technology firm (ticker OKLO).

  • Narayanadas Vivek

    General Counsel & Secretary of Oklo, reporting insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OKLOMed

UBS cuts Oklo stock price target to $41 on estimate updates

UBS reduced its price target for Oklo Inc. (NYSE:OKLO) to $41 from $55, citing updated estimates and maintaining a Neutral rating. The stock is down 68% over the past year. Oklo reported a wider-than-expected Q2 2026 loss but exceeded revenue forecasts, with $3.0 billion in cash. The company launched a $1 billion stock offering program. UBS and Truist Securities highlight near-term execution risks and progress in projects.

$OKLOMedAI 8/10

OKLO, XE Stocks Jump After-Hours — Trump Administration Taps Oklo, X-Energy In $200M Push To Power AI Data Centers

Oklo Inc. (OKLO) and X-Energy Inc. (XE) gained in after-hours trading after joining a $200M federal initiative to build nuclear power plants for AI data centers. The program includes Microsoft (MSFT) and Nvidia (NVDA), with $60M allocated to labs and universities. The initiative aims to accelerate reactor construction and reduce staffing needs, addressing rising electricity demand and grid strain.

$OKLOHigh

Nuclear Stocks Oklo, NuScale Power, and X

Shares of Oklo (OKLO), NuScale Power (SMR), and X-Energy (XE) surged after the U.S. House passed the Ratepayer Protection Act, which may boost demand for their small modular reactors as data center power sources. XE stock rose 12.08% to $16.33. Analysts see 106% upside for XE, with a $33.71 average price target.